
A new study, led by King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, has shown promising results, demonstrating that peanut oral immunotherapy (OIT) may be an effective treatment for adults with peanut allergies. The trial, known as
Read more
Researchers at the University of Bristol and the James Lind Alliance invite you to take part in the second phase of a UK-wide survey to prioritise the most urgent unanswered questions about childhood food allergy. This is the second part of the
Read more
A recent study led by researchers at the Icahn School of Medicine at Mount Sinai, New York, has provided encouraging evidence that a supervised, gradual peanut ingestion protocol may help children with a high-threshold peanut allergy increase their tolerance to
Read more
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
Read more
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
Read more
ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in
Read more
A recent announcement from DBV Technologies revealed promising long-term results from its EPITOPE Study. Results from a 3-year study showed that the VIASKIN® Peanut patch can help children with peanut allergies become less sensitive to peanuts, reducing the risk of
Read more
A group of health care professionals and patient representatives have created a Task Force on Food Allergen Ingestion Risk (‘FAIR’) within the European Academy of Allergy and Clinical Immunology (EAACI). This team is working to explore the challenges and needs
Read more
Living with allergies can sometimes feel isolating, especially when it seems like no one fully understands your struggles or when progress toward better solutions feels slow. However, it’s essential to look toward research to see the great strides being made
Read more